Cytosorbents Corp
CTSO
72 hedge funds and large institutions have $56.3M invested in Cytosorbents Corp in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 10 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
0.34% less ownership
Funds ownership: 26.75% → 26.41% (-0.34%)
6% less funds holding
Funds holding: 77 → 72 (-5)
13% less capital invested
Capital invested by funds: $64.6M → $56.3M (-$8.29M)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $19K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$801K |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$482K |
| 3 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$399K |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$315K |
| 5 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$306K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$744K |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$537K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$360K |
| 4 |
Renaissance Technologies
New York
|
-$294K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$240K |
CTSO Hedge Fund Activity: Q2 2019 in Review
72 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2019, worth a combined $56.3M — down 13% from $64.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CTSO and 8 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 25 added.
The largest buyer was Nuveen, opening a new position worth an estimated $801K. The largest seller was Millennium Management, exiting entirely with an estimated $744K sold.
- 72 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2019, down from 77 in Q1 2019.
- Funds reported $56.3M of Cytosorbents Corp stock for Q2 2019, down 13% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q2 2019 and 10 closed out, a net change of -2 holders.
- The largest Cytosorbents Corp buyer in Q2 2019 was Nuveen, an estimated $801K added.
- The largest Cytosorbents Corp seller in Q2 2019 was Millennium Management, an estimated $744K sold.
Based on aggregated 13F filings for Q2 2019.